Clinical trial
Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric…
NCT00209664 · Hokkaido Gastrointestinal Cancer Study Group, Other · Suspended
Key facts
| NCT number | NCT00209664 |
|---|---|
| Title | Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer |
| Official title | Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0303 |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | irinotecan, S-1 |
| Enrollment | 40 |
| Start date | Jan 1, 2004 |
| Completion | Dec 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 2, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: